ClinicalTrials.gg
RecruitingNCT07845656Updated Sep 29, 2026

A Home-based Multicomponent Exercise Intervention Program Based on the Fogg Behavior Model (FBM) for Older Adults With Osteosarcopenia and Frailty

An interventional study of Multi-component home-based exercise intervention based on the Fogg Behavior Model and routine health education and standard nursing care for osteoporosis and regular outpatient follow-up, without extra exercise and nutritional intervention. in Osteosarcopenia; Frailty; Older Adults, sponsored by Jiawei Jiang. Recruiting at 2 sites in China. Open to participants aged 60 Years to 85 Years. Per ClinicalTrials.gov, last updated 2026-09-29.

Sponsored by Jiawei Jiang · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 8 months after the study started (first participant enrolled Jan 2026, registered Sep 2026).
  • Started Jan 2026; still recruiting 10 months later.
Updated Sep 29, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
60 Years to 85 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 65 studies in Frailty with a site in China — 26 open to participants now, 28 under way, none of them phase 3. Frailty · China.

Planned enrollment
26th of 32
70 · median 146
Started
2026
with 5 others
No phase
26 of 65
12 open now
Primary completion
2026-12
later than 13 of 27 live
Registered
64th of 65
by date

Among the 65 studies in Frailty with a site in China, this one is the 26th largest by planned enrollment of the 32 interventional ones that give a count, is one of 6 that started in 2026, is one of 26 with no phase, reaches primary completion later than 13 of the 27 other live ones, and was the 64th registered.

Frailty

1,291 studies on the registry are indexed under Frailty; 454 are open to participants now.

Browse Frailty studies →

Open to participants now

26 of the 65 studies in Frailty with a site in China are open now. Recruiting first, the newest first:

20 more — sign in →

All 26 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 299 Frailty studies recruiting now, 235 (79%) set no upper age limit and 10 (3%) stop at 75 or younger; 7 take children under 18; 66 take healthy volunteers.

This study: 60 Years to 85 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 65 studies in Frailty with a site in China, or all of them as a file.
02

Study summary

This study aims to construct and evaluate a home-based multicomponent exercise intervention program based on the Fogg Behavior Model for older adults with osteosarcopenia and frailty. Eligible participants will be randomly divided into two groups. The intervention group will receive the home multicomponent exercise guidance built on Fogg Behavior Model, while the control group will get routine health education. We will compare frailty status, muscle strength, physical function,bone mineral density and quality of life between the two groups at baseline, 3 months and 6 months, to explore whether this intervention can improve physical function and reduce frailty in elderly patients with osteosarcopenia.

03

Conditions studied

  • Osteosarcopenia; Frailty; Older Adults

Browse trials for

Keywords

  • Osteosarcopenia, Frailty, Older adults, Exercise intervention, Fogg Behavior Model, Randomized controlled trial
04

Who can participate

Ages eligible
60 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. The disease is in stable condition.
  2. Aged 60-85 years or older.
  3. Meet the diagnostic criteria in the 2022 Expert Consensus on Sarcopenia-Osteoporosis.
  4. The score of frailty scale is ≥1, indicating patients are in pre-frailty or frailty status.
  5. Clear consciousness, normal communication, capable of cooperating with exercise intervention; not living alone and will not leave the residence within half a year.
  6. Own a smartphone and voluntarily participate in this study.

Exclusion criteria

Exclusion Criteria:

  1. Severe cardiopulmonary, hepatic or renal dysfunction.
  2. Uncontrolled severe neurological or psychiatric diseases.
  3. Recent fracture or unable to perform exercise training.
  4. Malignant tumor, severe infectious disease.
  5. Participate in other exercise intervention studies simultaneously.
  6. Cognitive impairment and cannot cooperate with follow-up.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
70 participants (estimated)

Study arms

  • Experimental
    Intervention group

    Home-based multi-component exercise intervention guided by Fogg Behavior Model, including resistance training, balance training and aerobic exercise for 6 months. Regular follow-up and behavior reminder will be provided.

    Behavioral: Multi-component home-based exercise intervention based on the Fogg Behavior Model

  • Active comparator
    Control group

    Routine health education about osteoporosis and sarcopenia. No systematic supervised exercise intervention.

    Behavioral: routine health education and standard nursing care for osteoporosis and regular outpatient follow-up, without extra exercise and nutritional intervention.

Interventions

  • BehavioralMulti-component home-based exercise intervention based on the Fogg Behavior Model

    Participants receive a 6-month multi-component home-based exercise intervention based on the Fogg Behavior Model, divided into 3 stages. Stage 1 (Weeks 1-2): motivation cultivation, health assessment, risk screening and health education. Stage 2 (Weeks 3-12): personalized exercise prescription including warm-up, aerobic, resistance, balance and flexibility training, with progressive intensity and regular follow-up. Stage 3 (Months 4-6): habit formation, self-management reinforcement and incentive strategies. The intervention aims to improve muscle mass, physical function and frailty status in older adults with sarcopenia-osteoporosis.

  • Behavioralroutine health education and standard nursing care for osteoporosis and regular outpatient follow-up, without extra exercise and nutritional intervention.

    Participants receive routine osteoporosis health education and standard nursing care. General advice on diet, fall prevention and daily activity is provided, without the multi-component staged exercise intervention based on the Fogg Behavior Model. Regular outpatient follow-up is arranged.

06

What researchers measure

Primary outcomes

  1. Change in frailty phenotype score at 6 months

    The change of Fried frailty phenotype score from baseline to 6-month follow-up. Fried frailty scale ranges from 0 to 5, higher score means worse frailty status.

    Time frame: Baseline, 3 months, 6 months

Secondary outcomes

  1. Change in handgrip strength at 6 months

    The change of handgrip strength (kg) from baseline to 6-month follow-up

    Time frame: Baseline, 3 months,6 months

  2. Change in Short Physical Performance Battery (SPPB) score at 6 months

    The change of SPPB score from baseline to 6-month follow-up. SPPB ranges from 0 to 12, higher score indicates better physical performance.

    Time frame: Baseline,3 months, 6 months

  3. Change in skeletal muscle mass index (SMI) at 6 months

    The change of skeletal muscle mass index (kg/m²) from baseline to 6-month follow-up, assessed by bioelectrical impedance analysis.

    Time frame: Baseline,3 months, 6 months

  4. Change in bone mineral density (BMD) at 6 months

    The change of lumbar spine bone mineral density (g/cm²) from baseline to 6-month follow-up, measured by dual-energy X-ray absorptiometry (DXA).

    Time frame: Baseline,6 months

  5. Change in quality of life at 6 months

    The change of quality of life measured by the 12-item Short Form Health Survey (SF-12) from baseline to 6-month follow-up.

    Time frame: Baseline,3 months, 6 months

  6. Incidence of falls within 6 months

    The number of participants who experienced fall events during the 6-month intervention period.

    Time frame: 6 months

07

Study locations

2 of 2 sites recruiting
  • Nantong First People's Hospital
    Nantong, Jiangsu 226000, China
    Recruiting
  • Nantong First People's Hospital
    Nantong, Jiangsu 226001, China
    Recruiting
    • Li Sun, Master' degree · Contactsunliborntowin@126.com · 8615896264283
    • Yan Hai Gu, Bachelor · Sub investigator
    • Qian Zhi Gong, Master · Sub investigator
    • Hua Guan Xu, Doctor · Sub investigator
    • Yu Yu Sun, Doctor · Principal investigator
    • Qin Xuan, Bachelor · Sub investigator
    • Yan Dong Zhu, Master · Sub investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2026 (actual). Primary completion is estimated for Dec 2026, 11 months after the start.

Of 514 non-industry interventional studies with no phase under Frailty, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 39. This study's planned 11 months is below that.

Counting every sponsor, half of 519 studies reached it within 22 months; a quarter within 10 and three quarters within 39.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 23, 2026
First posted
Sep 29, 2026
StartActual
Jan 1, 2026
Primary completionEst.
Dec 31, 2026
CompletionEst.
Jun 30, 2027
Last update
Sep 29, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Sep 29, 2026
Show all 1 update
  1. Sep 29, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07845656
Lead sponsor
Jiawei Jiang
Responsible party
Jiawei Jiang (Attending Physician, Affiliated 2 Hospital of Nantong University) — Sponsor-investigator
First posted
Sep 29, 2026
Start date
Jan 1, 2026
Primary completion
Dec 31, 2026 (estimated)
Completion
Jun 30, 2027 (estimated)
Last update
Sep 29, 2026

Study contacts

Li Sun, Master' degree
Contact
sunliborntowin@126.com
8615896264283

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion